RPA3 and cancer: Furthermore, functional experiments demonstrated that <i>RPA3</i> knockdown suppressed cancer cell proliferation and migration, sensitized cells to cisplatin treatment, and reduced global lactylation, which may serve as a novel biomarker and potential therapeutic target.